Jingyi Hu

机构：China Pharmaceutical University, Wuxi Municipal Product Quality Supervision and Inspection Institute, Wuxi Institute of Technology · ORCID：0009-0001-1020-1469

发表论文 3 篇 · 总被引 28 次 · h-index 3

代表论文

• Versatile hydrogel-based drug delivery platform for multimodal cancer therapy from bench to bedside (2024 · Applied Materials Today · 被引 21)
• Immune‐Engineered Hydrogels Combat Orthotopic and Metastatic Cancer via Hypoxia‐Relieved Photodynamic Therapy and Ferroptotic Cell Death (2026 · Advanced Functional Materials · 被引 4)
• A violet phosphorus-engineered immunogel for combating TNBC progression via tumor microenvironment remodeling (2026 · Nano Today · 被引 3)